Drawing for KOKO

USPTO serial 90809412

KOKO

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
—
Examiner
CHANG, KATHERINE S
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with KOKO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Goods and services

ClassDescriptionStatusFirst use
009Downloadable medical software for controlling, spotting trends in and managing patient medical information, for telemedicine communication, for patient monitoring, for data management and for data mining; downloadable software as a medical device (SaMD) for use as a medical instrument for spirometry and plethysmography; recorded software for controlling and managing patient medical information, for completing disease based questionnaires, for telemedicine communication, for patient monitoring, for data management and for data mining; downloadable mobile applications for controlling and managing patient medical information, for telemedicine communication, for patient monitoring, for data management for and data mining; communication hubsACTIVE—
010Medical equipment, namely, hand-held electronic spirometers capable of communicating with other electronic devices, biologic filters specially adapted for hand-held electronic spirometers capable of communicating with other electronic devices, calibration syringes for medical purposes, medical gas dosimeters for diagnostic purposes for performing airway challenge protocols to assess the severity of certain respiratory diseases, and lung analyzers for medical diagnostic purposes; wearable monitors used to measure biometric data for medical use; patient medical monitors for monitoring sleep patterns, blood pressure, heart rate, and lung function for medical diagnostic purposes; portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device; therapeutic inhalers, sold empty, with sensors to monitor prescription adherence; wearable monitors used to measure biometric data for medical use and related recorded software sold as a unit; patient medical monitors for monitoring sleep patterns, blood pressure, heart rate, and lung function for medical diagnostic purposes and related recorded software sold as a unit; portable medical devices with sensors to monitor the physical movements of a patient wearing or carrying the device and related recorded software sold as a unitACTIVE—
042Platform as a service (PAAS) featuring computer software platforms in the field of telehealth and telemedicine for allowing patients and doctors to communicate over the internet; data mining; software as a service (SAAS) services featuring software using predictive algorithms for monitoring chronic pulmonary disease; software as a service (SAAS) services featuring software using predictive algorithms for spotting health trends and warning signs, and suggesting solutions; providing temporary use of on-line non-downloadable software for controlling and managing patient medical information, for providing disease based questionnaires, for telemedicine communication, for patient monitoring, for data management and for data miningACTIVE—
044Telemedicine services; remote monitoring of data indicative of the health or condition of an individual or group of individuals for medical diagnosis and treatment purposes; providing an internet website for medical professionals and medical patients featuring medical information from remote locations via electronic patient monitoring devices that feed information to the web site that can be accessed in real-time by medical professionals for purposes of monitoring and diagnosing medical conditions; health care services, namely, providing a database in the fields of spirometry and plethysmography information and featuring inputting and collection of data and information all for treatment and diagnostic purposes; electronic monitoring and reporting of biometric data using computers or sensors for medical diagnosis and treatment purposesACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jul 12, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jul 1, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Nov 28, 2023NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 3, 2023NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 3, 2023PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 13, 2023NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Aug 27, 2023CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 12, 2023RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION—
Apr 6, 2023WOAGWITHDRAWAL OF ATTORNEY GRANTED—
Apr 6, 2023WOARTEAS WITHDRAWAL OF ATTORNEY RECEIVED—
Apr 6, 2023CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Apr 6, 2023TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Apr 6, 2023COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jan 30, 2023RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED—
Aug 2, 2022GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Aug 2, 2022GNSLLETTER OF SUSPENSION E-MAILED—
Aug 2, 2022CNSLSUSPENSION LETTER WRITTEN—
Jul 16, 2022TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Jul 15, 2022CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Jul 15, 2022TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Feb 18, 2022GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2022GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 18, 2022CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Feb 14, 2022DOCKASSIGNED TO EXAMINER—
Sep 14, 2021NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 6, 2021NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance